Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel
Status:
Recruiting
Trial end date:
2024-10-31
Target enrollment:
Participant gender:
Summary
The current multicenter prospective phase II study aims to evaluate the safety and efficacy
of preoperative FLOT therapy for esophageal squamous cell carcinoma.